SG

Stacie M. Goldberg

BS Bristol-Myers Squibb: 8 patents #11 of 598Top 2%
📍 Potomac, MD: #4 of 139 inventorsTop 3%
🗺 Maryland: #43 of 4,079 inventorsTop 2%
Overall (2019): #12,640 of 560,194Top 3%
8
Patents 2019

Issued Patents 2019

Showing 1–8 of 8 patents

Patent #TitleCo-InventorsDate
10323092 Cancer immunotherapy by disrupting PD-1/PD-L1 signaling John P. Cogswell, Ashok K. Gupta, Maria Jure-Kunkel, Xi-Tao Wang, Jon M. Wigginton 2019-06-18
10323093 Cancer immunotherapy by disrupting PD-1/PD-L1 signaling John P. Cogswell, Ashok K. Gupta, Maria Jure-Kunkel, Xi-Tao Wang, Jon M. Wigginton 2019-06-18
10316090 Cancer immunotherapy by disrupting PD-1/PD-L1 signaling John P. Cogswell, Ashok K. Gupta, Maria Jure-Kunkel, Xi-Tao Wang, Jon M. Wigginton 2019-06-11
10316091 Cancer immunotherapy by disrupting PD-1/PD-L1 signaling John P. Cogswell, Ashok K. Gupta, Maria Jure-Kunkel, Xi-Tao Wang, Jon M. Wigginton 2019-06-11
10308714 Cancer immunotherapy by disrupting PD-1/PD-L1 signaling John P. Cogswell, Ashok K. Gupta, Maria Jure-Kunkel, Xi-Tao Wang, Jon M. Wigginton 2019-06-04
10266594 Cancer immunotherapy by disrupting PD-1/PD-L1 signaling John P. Cogswell, Ashok K. Gupta, Maria Jure-Kunkel, Xi-Tao Wang, Jon M. Wigginton 2019-04-23
10266595 Cancer immunotherapy by disrupting PD-1/PD-L1 signaling John P. Cogswell, Ashok K. Gupta, Maria Jure-Kunkel, Xi-Tao Wang, Jon M. Wigginton 2019-04-23
10266596 Cancer immunotherapy by disrupting PD-1/PD-L1 signaling John P. Cogswell, Ashok K. Gupta, Maria Jure-Kunkel, Xi-Tao Wang, Jon M. Wigginton 2019-04-23